Naproxen Sodium
- Product NDC
- 21695-090
- 11-digit product format
- 216950090
- Labeler code
- 21695
- Product ID
- 21695-090_0c01cb34-0d6b-4248-afde-82d4d934dabd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- ANDA078432
- Marketing category
- ANDA
- Marketing start
- 2007-04-26
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 550 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-090-14 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-20 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-28 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-56 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-60 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
| 21695-090-90 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4764-48b1-e053-8cdaa90a720a | Naproxen Sodium Tablets, USP 275 mg and 550 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-090-14 | Naproxen Sodium | 14 in 1 BOTTLE | TABLET | 14 | 1 | |
| 21695-090-20 | Naproxen Sodium | 20 in 1 BOTTLE | TABLET | 20 | 1 | |
| 21695-090-28 | Naproxen Sodium | 28 in 1 BOTTLE | TABLET | 28 | 1 | |
| 21695-090-30 | Naproxen Sodium | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 21695-090-56 | Naproxen Sodium | 56 in 1 BOTTLE | TABLET | 56 | 1 | |
| 21695-090-60 | Naproxen Sodium | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 21695-090-90 | Naproxen Sodium | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-090-14 | EA - Each | 21695-090 | 1eb70789-bc25-497e-9158-1d2951bdbc4e | 1 | 2012-07-24 |
| 21695-090-20 | EA - Each | 21695-090 | a21c208b-3779-4df7-a431-206533b11912 | 1 | 2012-07-24 |
| 21695-090-28 | EA - Each | 21695-090 | ae76e7c9-99bb-4a86-9f0c-2a9c87faf156 | 1 | 2012-07-24 |
| 21695-090-30 | EA - Each | 21695-090 | d535edae-350e-4b3a-b49c-7218f1cdf40e | 1 | 2012-07-24 |
| 21695-090-56 | EA - Each | 21695-090 | c67aba18-fab0-420e-8e8d-f7b089bd6b0b | 1 | 2012-07-24 |
| 21695-090-60 | EA - Each | 21695-090 | f9e518fe-aa6f-4d6f-9681-e75fc565d4fd | 1 | 2012-07-24 |
| 21695-090-90 | EA - Each | 21695-090 | 5063a2a7-5a58-4389-8e57-f5af4f04ecfb | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NAPROXEN SODIUM | ACTIVE INGREDIENT | 9TN87S3A3C | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | NAPROXEN SODIUM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 849431 | naproxen sodium 550 MG Oral Tablet | PSN | 0c01cb34-0d6b-4248-afde-82d4d934dabd | 1 |
| 849431 | naproxen sodium 550 MG Oral Tablet | SCD | 0c01cb34-0d6b-4248-afde-82d4d934dabd | 1 |
| 849431 | naproxen sodium 550 MG (as naproxen 500 MG) Oral Tablet | SY | 0c01cb34-0d6b-4248-afde-82d4d934dabd | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 21695-090-14 | 21695009014 | 14 in 1 BOTTLE | Historical |
| 21695-090-20 | 21695009020 | 20 in 1 BOTTLE | Historical |
| 21695-090-28 | 21695009028 | 28 in 1 BOTTLE | Historical |
| 21695-090-30 | 21695009030 | 30 in 1 BOTTLE | Historical |
| 21695-090-56 | 21695009056 | 56 in 1 BOTTLE | Historical |
| 21695-090-60 | 21695009060 | 60 in 1 BOTTLE | Historical |
| 21695-090-90 | 21695009090 | 90 in 1 BOTTLE | Historical |